• Pathway Genomics, IBM Health App

    ZDNet | Pathway Genomics last week announced that the app the company has been developing with IBM Watson is now in closed alpha release.

    Jan 12, 2016

  • Jolly Jay Flatley Ushers in Another Big Year for Illumina

    Bio-IT World | The JP Morgan Healthcare Conference comes but once a year. Now it’s here, now it’s here, and Illumina CEO Jay Flatley has honored his seasonal tradition by releasing a new next-generation sequencer in his address to investors.

    Jan 12, 2016

  • Illumina Spinoff GRAIL to Trial Liquid Biopsies for Early Detection of Cancer

    Bio-IT World | Illumina, the dominant manufacturer of DNA sequencing technology, has formed a spinoff company called GRAIL to experiment with a pan-cancer blood test, an undertaking for which hundreds of thousands of patients may be enrolled in clinical studies.

    Jan 11, 2016

  • You're Probably Not Mostly Microbes

    The Atlantic | A new study revises the most famous "fact" about the microbiome: that microbes outnumber human cells in the body ten to one.

    Jan 8, 2016

  • BioMérieux and Illumina Use Whole Genome Sequencing to Monitor Hospital Infections

    Bio-IT World | In partnership with Illumina, multinational diagnostics company bioMérieux has launched EpiSeq, the first commercial system to monitor outbreaks in hospitals by sequencing and analyzing the whole genomes of bacteria.

    Jan 8, 2016

  • Moderna Signs Deal with Contract Researcher to Bring mRNA Therapies Into Clinical Trials

    FierceBiotech | Moderna Therapeutics, a high-profile private biotech with scores of preclinical projects, is finally moving toward human trials, recruiting one of the world's largest CROs to help get its much-hyped pipeline moving.

    Jan 8, 2016

  • A Precision Medicine Blitz in China

    Nature News | A new push by the Chinese government for research in genomic health is expected to dwarf the U.S. Precision Medicine Initiative in both scale and funding, although China's shortage of physicians and drug development capacity may make it hard to capitalize on new discoveries.

    Jan 6, 2016

  • Editas Medicine Files for CRISPR Technology's First IPO

    Bio-IT World | Still facing a looming patent dispute over its most basic intellectual property, Editas Medicine registered with the SEC for an initial public offering this week, making it the first therapeutics company based on CRISPR-Cas9 gene editing to go public.

    Jan 5, 2016

  • Who Can Host Biology's Big Data?

    Forbes | The National Institutes of Health expects to shortly phase out its funding for the maintenance of databases like Online Mendelian Inheritance in Man, leaving the future of these invaluable resources for the life sciences uncertain.

    Jan 4, 2016

  • December News and Product Briefs

    Bio-IT World | The latest products and announcements from around the industry, including the tranSMART Foundation absorbing the OpenBEL project, and an expanded organs-on-chips program at Merck.

    Dec 30, 2015

  • Silicon Valley's Dubious Biotech Investments

    The Verge | Verge Editors Elizabeth Lopatto and Ben Popper discuss high-tech investors' vulnerability to shaky claims in the life sciences.

    Dec 29, 2015

  • The Fuzzy Definition of 'GMO'

    Grist | The tangled history of agricultural technology, and nature's dazzling array of genetic interventions, make it intractably hard to come up with a crisp, consistent meaning for "genetically modified organism."

    Dec 28, 2015

  • Wellcome Trust Introduces Mykrobe Predictor for Genetic Analysis of Antibiotic Resistance

    Bio-IT World | A large team of researchers led by Zamin Iqbal of the Wellcome Trust Centre for Human Genetics has published a new software tool that rapidly identifies antibiotic-resistant bacteria using DNA data, beginning with studies of Staphylococcus aureus and Mycobacterium tuberculosis.

    Dec 23, 2015

  • Foundation Medicine, UnitedHealthcare Sign Lung Cancer Profiling Agreement

    Bio-IT World News Brief | Foundation Medicine has signed an agreement with UnitedHealthcare to offer FoundationOne, a comprehensive genomic profiling assay for solid tumors, to patients with metastatic stage IV non-small cell lung cancer (NSCLC).

    Dec 22, 2015

  • Triumph of the Public Cloud

    Wired | A decade after the launch of Amazon Web Services, there has been a seismic shift in attitudes toward the transfer of computing to cloud services.

    Dec 22, 2015

  • OrbiMed Launches New VC Fund with $950m

    Bio-IT World News Brief | OrbiMed, a leading investment firm focused on the healthcare sector, today announced the closing of its next venture capital fund, OrbiMed Private Investments VI, LP, with $950 million in limited partner commitments.

    Dec 21, 2015

  • Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture

    Xconomy | Bayer and CRISPR Therapeutics have signed a pact that could be worth more than $335 million to develop CRISPR-based drugs for a variety of diseases starting with blindness, blood disorders, and congenital heart disease.

    Dec 21, 2015

  • The Personal Genome Project, Ten Years Later

    Techonomy | A decade ago, the Personal Genome Project became the first massive study of people sharing their full genome information. Many thought it unlikely to succeed.

    Dec 18, 2015

  • Juniper warns about spy code in firewalls

    Computerworld | Juniper, a major manufacturer of networking equipment, said on Thursday it found spying code planted in certain models of its firewalls, an alarming discovery that echoes of state-sponsored tampering.

    Dec 18, 2015

  • AMP, FDA Debate Regulation of Laboratory-Developed Tests

    Bio-IT World | The Association of Molecular Pathology (AMP) accused the Food and Drug Administration of fabricating some of the examples included in a recent FDA report outlining the public health evidence for FDA oversight of laboratory-developed tests.

    Dec 17, 2015